These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


424 related items for PubMed ID: 14532989

  • 21. Comparison of hexamethylhypericin and tetrabromohypericin to hypericin for their in vivo efficacy as PDT tools.
    Delaey E, Zupko I, Chen B, Derycke A, van Laar F, De Vos D, De Witte P.
    Int J Oncol; 2003 Aug; 23(2):519-24. PubMed ID: 12851704
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of Hypocrellin B in a human bladder tumor model in experimental photodynamic therapy: biodistribution, light dose and drug-light interval effects.
    Chin W, Lau W, Cheng C, Olivo M.
    Int J Oncol; 2004 Sep; 25(3):623-9. PubMed ID: 15289863
    [Abstract] [Full Text] [Related]

  • 23. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy.
    Chen B, Zupkó I, de Witte PA.
    Int J Oncol; 2001 Apr; 18(4):737-42. PubMed ID: 11251168
    [Abstract] [Full Text] [Related]

  • 24. Photosensitizing and radiosensitizing effects of hypericin on human renal carcinoma cells in vitro.
    Wessels JT, Busse AC, Rave-Fränk M, Zänker S, Hermann R, Grabbe E, Müller GA.
    Photochem Photobiol; 2008 Apr; 84(1):228-35. PubMed ID: 18173725
    [Abstract] [Full Text] [Related]

  • 25. Microscopic quantification of hypercin fluorescence in an orthotopic rat bladder tumor model after intravesical instillation.
    Kamuhabwa AA, Roskams T, Baert L, De Witte PA.
    Int J Oncol; 2003 Apr; 22(4):933-7. PubMed ID: 12632090
    [Abstract] [Full Text] [Related]

  • 26. Hypericin-mediated photodynamic therapy elicits differential interleukin-6 response in nasopharyngeal cancer.
    Du H, Bay BH, Mahendran R, Olivo M.
    Cancer Lett; 2006 Apr 28; 235(2):202-8. PubMed ID: 15935550
    [Abstract] [Full Text] [Related]

  • 27. Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer.
    Khot MI, Perry SL, Maisey T, Armstrong G, Andrew H, Hughes TA, Kapur N, Jayne DG.
    Photodiagnosis Photodyn Ther; 2018 Sep 28; 23():221-229. PubMed ID: 29969677
    [Abstract] [Full Text] [Related]

  • 28. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin.
    Kamuhabwa AA, Roskams T, D'Hallewin MA, Baert L, Van Poppel H, de Witte PA.
    Int J Cancer; 2003 Nov 10; 107(3):460-7. PubMed ID: 14506748
    [Abstract] [Full Text] [Related]

  • 29. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids.
    Marchal S, Fadloun A, Maugain E, D'Hallewin MA, Guillemin F, Bezdetnaya L.
    Biochem Pharmacol; 2005 Apr 15; 69(8):1167-76. PubMed ID: 15794937
    [Abstract] [Full Text] [Related]

  • 30. Biodistribution and photodynamic effects of polyvinylpyrrolidone-hypericin using multicellular spheroids composed of normal human urothelial and T24 transitional cell carcinoma cells.
    Vandepitte J, Roelants M, Van Cleynenbreugel B, Hettinger K, Lerut E, Van Poppel H, de Witte PA.
    J Biomed Opt; 2011 Apr 15; 16(1):018001. PubMed ID: 21280926
    [Abstract] [Full Text] [Related]

  • 31. Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy.
    Bobrov N, Cavarga I, Longauer F, Rybárová S, Fedorocko P, Brezáni P, Miskovský P, Mirossay L, Stubna J.
    Phytomedicine; 2007 Feb 15; 14(2-3):172-8. PubMed ID: 17095201
    [Abstract] [Full Text] [Related]

  • 32. The multifaceted photocytotoxic profile of hypericin.
    Theodossiou TA, Hothersall JS, De Witte PA, Pantos A, Agostinis P.
    Mol Pharm; 2009 Feb 15; 6(6):1775-89. PubMed ID: 19739671
    [Abstract] [Full Text] [Related]

  • 33. [Photodynamic therapy mediated with 5-aminolevulinic acid for C6 glioma spheroids].
    Kamoshima Y, Terasaka S, Iwasaki Y.
    Hokkaido Igaku Zasshi; 2008 May 15; 83(3):167-73. PubMed ID: 18546870
    [Abstract] [Full Text] [Related]

  • 34. p53 Status does not affect photodynamic cell killing induced by hypericin.
    Lee HB, Ho AS, Teo SH.
    Cancer Chemother Pharmacol; 2006 Jul 15; 58(1):91-8. PubMed ID: 16211395
    [Abstract] [Full Text] [Related]

  • 35. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
    Chen B, Roskams T, de Witte PA.
    Lasers Surg Med; 2002 Jul 15; 31(3):158-63. PubMed ID: 12224088
    [Abstract] [Full Text] [Related]

  • 36. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin.
    Du HY, Li Y, Olivo M, Yip GW, Bay BH.
    Oncol Rep; 2006 Dec 15; 16(6):1397-402. PubMed ID: 17089067
    [Abstract] [Full Text] [Related]

  • 37. Hypericin-mediated photocytotoxic effect on HT-29 adenocarcinoma cells is reduced by light fractionation with longer dark pause between two unequal light doses.
    Sacková V, Kuliková L, Mikes J, Kleban J, Fedorocko P.
    Photochem Photobiol; 2005 Dec 15; 81(6):1411-6. PubMed ID: 16354114
    [Abstract] [Full Text] [Related]

  • 38. Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy.
    Davids LM, Kleemann B, Cooper S, Kidson SH.
    Cell Biol Int; 2009 Oct 15; 33(10):1065-72. PubMed ID: 19596456
    [Abstract] [Full Text] [Related]

  • 39. Photoactivation of hypericin down-regulates glutathione S-transferase activity in nasopharyngeal cancer cells.
    Du HY, Olivo M, Tan BK, Bay BH.
    Cancer Lett; 2004 Apr 30; 207(2):175-81. PubMed ID: 15072826
    [Abstract] [Full Text] [Related]

  • 40. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
    Roelants M, Lackner B, Waser M, Falk H, Agostinis P, Van Poppel H, de Witte PA.
    Photochem Photobiol Sci; 2009 Jun 30; 8(6):822-9. PubMed ID: 19492110
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.